Lv4
424 积分 2025-06-25 加入
Discovery of a Novel Silybin Derivative for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
20小时前
已完结
Discovery of the First-In-Class HSD17B13/PPAR Multitarget Modulators for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
21小时前
已完结
Correction to Synthesis and Biological Evaluation of 5-Benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione Derivatives for the Treatment of Obesity-Related Nonalcoholic Fatty Liver Disease
21小时前
已关闭
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease
21小时前
已完结
Microbial Production and Industrial Applications of ( S )-Equol for Precision Health and Functional Food Innovation
25天前
已完结
Equol, a Metabolite of Daidzein, Inhibits IgE-Dependent Basophil Activation by Modulating Intracellular Signaling
25天前
已完结
The phytoestrogen equol protects mice against acetaminophen hepatotoxicity
25天前
已完结
Relationship between urinary phytoestrogen metabolites and telomere length: a cross-sectional study from the National Health and Nutrition Examination Survey
25天前
已完结
Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist
3个月前
已完结
Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)
3个月前
已完结
皖公网安备34019202002308
